[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Home

Learning Objectives
Accreditation
Speaker Biographies

 

View Video Presentation

Presentation Transcript
Download Slides
Online Quiz

CFR Regulations
Drug Information
FDA Advisory Committees
Orange Book
OTC Fed. Reg. Publications


Technical Support
Contact Us

















 



Online Training Seminar

'Drug Review and Related Activities
in the United States'


Revised September 2004

EDUCATIONAL PURPOSE:

This seminar provides viewers with an overview of the Food and Drug Administration's role in the drug development and review process.

This seminar examines various aspects of the Investigational and New Drug Application (IND/NDA) processes, including clinical drug testing in patients, the importance of the Prescription Drug User Fee Act (PDUFA), FDA Modernization Act (FDAMA), generic drugs and post-marketing surveillance.

 

LEARNING OBJECTIVES:

Upon completion of this program, the health care professional will be able to:

1) Explain the drug development process in the United States.

2) State how to obtain current drug information from the FDA.

 Advance to Next Section....

  


Main FDA number: 1-888-INFO-FDA (1-888-463-6332)
Drug Information Number: 301-827-4570  (8:00 am - 4:30 pm Eastern Time)

 

Page Last Updated: February 2, 2006

 
horizonal rule